Antalium Inc. and Neuroceptor Inc., two spin-off companies of 平特五不中 and Queen's Universities respectively, have merged to form a new leading-edge biopharmaceutical company called PainCeptor Pharma Corporation. The new company is focused on the development of novel and effective therapeutic drugs for the treatment of acute and chronic pain.